Clinical Trial Update: Does Psilocybin Require Psychedelic Effects to Treat Depression? [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is exploring whether psilocybin's psychedelic effects are necessary to treat treatment-resistant depression, and the study is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Treatment-resistant Depression

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: Centre for Addiction and Mental Health | Conditions: Treatment-resistant Depression | Phase 2 | Status: RECRUITING